Climb Bio Inc: Baird assumes coverage with outperform rating; target price $21
CLYM•Related News
U.S. oil may retest support at $80.70
XLE•
Chevron Corporation <CVX.N>: Jefferies Raises Target Price to $233 From $216
CVX•
ExxonMobil <XOM.N>: Jefferies raises target price to $200 from $184
XOM•
ServiceNow study shows Singapore agentic AI adoption jumps to 51% in 2026
NOW•
Canadian Natural Resources Ltd <CNQ.TO>: Jefferies raises target price to C$70 from C$64
CNQ•